Craft

Eurofins

Stock Price

€46.4

2024-10-29

Market Capitalization

€8.8 B

2024-10-29

Revenue

€7 B

FY, 2024

Eurofins Summary

Company Summary

Overview
Eurofins Scientific is a life sciences company providing laboratory testing solutions. It offers food and feed, environmental and cosmetic product testing, and agroscience contract research organization (CRO) services. The company also delivers testing and laboratory services for genomics, discovery pharmacology, forensics, contract development and manufacturing organization (CDMO), advanced material sciences, etc.
Type
Public
Status
Active
Founded
1987
HQ
Luxembourg, LU | view all locations
Website
https://www.eurofins.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Gilles G. Martin

    Gilles G. Martin, Chairman of the Board and Chief Executive Officer

    • Laurent Lebras

      Laurent Lebras, Group Finance & Administration Director

    • Timothy S. Oostdyk

      Timothy S. Oostdyk, Executive Vice President BioPharma, Genomics, Agrosciences Services and Clinical Diagnostic Services, North America and Direct To Consumer Testing

    • Christian Wurst

      Christian Wurst, Chief Operating Officer, Food & Environment Testing

    Operating MetricsView all

    Laboratories

    900

    FY, 2023

    Countries

    62
    1.6%

    FY, 2023

    Tests Performed Annually

    450M

    FY, 2023

    LocationsView all

    774 locations detected

    • Luxembourg, District de Luxembourg HQ

      Luxembourg

      23 Val Fleuri

    • Alachua, FL

      United States

      13709 Progress Blvd s 163

    • Arvada, CO

      United States

      4955 Yarrow St

    • Ashland, VA

      United States

      10329 Stony Run Ln

    • Austin, TX

      United States

      13501 McCallen Pass

    • Avon, CT

      United States

      200 W Main St

    and 768 others

    Eurofins Financials

    Summary Financials

    Revenue (FY, 2024)
    €7.0B
    Gross profit (FY, 2024)
    €4.7B
    Net income (FY, 2024)
    €405.5M
    Cash (FY, 2024)
    €613.9M
    EBIT (FY, 2024)
    €681.5M
    Enterprise value
    $11.8B

    Footer menu